Treatment for Nicotine Use Disorder Among Medicaid-Enrolled Adolescents and Young Adults.
Where this comes from
- Record sourced from PubMed, PMID 31545354.
- Also identified by DOI 10.1001/jamapediatrics.2019.3200 and PMC identifier 6763988.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study assesses use of nicotine replacement therapy, varenicline, and sustained-release bupropion for adolescents and young adults with nicotine use disorder who are enrolled in Medicaid.